Xosomix LLC Profile last edited on: 1/29/2024
CAGE: 8SWZ1
UEI: KCWEJH659NZ9
Business Identifier: Next generationof therapeutics based on exosomes. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 50
County: San Diego
Congr. District: 50
County: San Diego
Public Profile
Anchored in preclinical research demonstrating the first therapeutic use of exosomes in a brain disorder - and resident in the biotech incubator JLABS by Johnson & Johnson Innovation - Xosomix is a biotechnology company addressing development of the next generation therapeutics using exosomes. The firm is anchored in the preclinical research undertaken to demonstrate the first therapeutic use of exosomes in a brain disorder, Rett Syndrome.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2022 | 1 | NIH | $318,909 | |
| Project Title: Quantitative proteomic profiling of extracellular vesicles from menstrualeffluent for the discovery of non-invasive diagnostic biomarkers of endometriosis | ||||
Key People / Management
Pranav Sharma
Company News
There are no news available.
